Anhoque Carolina Fiorin, Domingues Simone Cristina Aires, Carvalho Thiago, Teixeira Antônio Lúcio, Domingues Renan Barros
Neuroscience Postgraduation Program, Federal University of Minas Gerais, Belo Horizonte MG, Brazil.
Arq Neuropsiquiatr. 2011 Dec;69(6):882-6. doi: 10.1590/s0004-282x2011000700006.
Depression and anxiety have been reported in patients with multiple sclerosis (MS) and in patients with clinically isolated syndrome (CIS). However, the precise mechanisms that lead to depressive and anxiety symptoms in these patients are still unclear. In this study we evaluated with the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI) patients with MS and CIS and compared them to controls. We also correlated BDI and BAI scores with clinical parameters. Kruskall-Wallis followed by Dunn's Multiple Comparison Test, Chi-square and Spearman test were used. Patients with MS had higher depressive and anxiety scores than controls. The BDI and BAI scores of patients with CIS were not significantly different from controls. There was a positive correlation between BDI, BAI and EDSS. Our results corroborate the view that MS patients have higher depression and anxiety levels than control subjects. Anxiety and depressive symptoms also seem to progress according to the severity of the disease.
据报道,多发性硬化症(MS)患者和临床孤立综合征(CIS)患者存在抑郁和焦虑症状。然而,导致这些患者出现抑郁和焦虑症状的确切机制仍不清楚。在本研究中,我们使用贝克抑郁量表(BDI)和贝克焦虑量表(BAI)对MS和CIS患者进行评估,并将他们与对照组进行比较。我们还将BDI和BAI评分与临床参数进行关联分析。采用Kruskal-Wallis检验,随后进行Dunn多重比较检验、卡方检验和Spearman检验。MS患者的抑郁和焦虑评分高于对照组。CIS患者的BDI和BAI评分与对照组无显著差异。BDI、BAI与扩展残疾状态量表(EDSS)之间存在正相关。我们的结果证实了MS患者的抑郁和焦虑水平高于对照组的观点。焦虑和抑郁症状似乎也随着疾病的严重程度而加重。